In quiescent endothelial cells, angiopoietin-1 stimulates Tie2, but during inflammation, angiopoietin-2 competitively inhibits Tie2, favoring endothelial dysfunction that could be targeted using adenoviral constructs expressing the protective angiopoietin-1. Here, TEK is linked to endothelial dysfunction.